Arcadia Biosciences (RKDA) Other Accumulated Expenses (2014 - 2025)

Arcadia Biosciences has reported Other Accumulated Expenses for 12 years, with the latest figure at $270000.0 in Q3 2025.

• For the quarter ending Q3 2025, Other Accumulated Expenses rose 800.0% year-over-year to $270000.0; the trailing twelve-month figure through Sep 2025 stood at $270000.0 (up 800.0% YoY), and the FY2024 full-year result was $172000.0, up 290.91% from the prior year.
• Other Accumulated Expenses for Q3 2025 stood at $270000.0, roughly flat from $270000.0 in the prior quarter.
• The five-year high for Other Accumulated Expenses was $298000.0 in Q4 2022, with the low at $30000.0 in Q3 2024.
• Historically, Other Accumulated Expenses has averaged $203222.2 across 5 years, with a median of $264000.0 in 2021.
• Annual changes were most pronounced in 2023 — Other Accumulated Expenses plunged 87.87% — and 2025, when it surged 800.0%.
• Arcadia Biosciences' Other Accumulated Expenses stood at $264000.0 in 2021, then gained by 12.88% to $298000.0 in 2022, then sank by 85.23% to $44000.0 in 2023, then surged by 290.91% to $172000.0 in 2024, then surged by 56.98% to $270000.0 in 2025.
• The last three Other Accumulated Expenses figures came in at $270000.0 (Q3 2025), $270000.0 (Q1 2025), and $172000.0 (Q4 2024), per Business Quant data.